Wealth Enhancement Advisory Services
CRL icon

Wealth Enhancement Advisory Services’s Charles River Laboratories CRL Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$909K Buy
3,896
+38
+1% +$6.77K ﹤0.01% 2142
2026
Q1 		$671K Sell
3,858
-2,288
-37% -$424K ﹤0.01% 2101
2025
Q4 		$1.33M Buy
6,146
+229
+4% +$41.5K ﹤0.01% 1783
2025
Q3 		$1.01M Buy
5,917
+918
+18% +$146K ﹤0.01% 1864
2025
Q2 		$785K Sell
4,999
-724
-13% -$96.5K ﹤0.01% 1893
2025
Q1 		$861K Sell
5,723
-247
-4% -$41.4K ﹤0.01% 1680
2024
Q4 		$1.1M Buy
5,970
+187
+3% +$36K ﹤0.01% 1485
2024
Q3 		$1.14M Sell
5,783
-331
-5% -$68.8K ﹤0.01% 1320
2024
Q2 		$1.26M Buy
6,114
+1,535
+34% +$348K ﹤0.01% 1172
2024
Q1 		$1.24M Sell
4,579
-37
-0.8% -$8.84K ﹤0.01% 1140
2023
Q4 		$1.09M Buy
4,616
+63
+1% +$12.4K ﹤0.01% 1138
2023
Q3 		$892K Buy
+4,553
New +$935K ﹤0.01% 1150
2021
Q4 		– Sell
-19,303
Closed -$8.3M – 306
2021
Q3 		$8.3M Buy
+19,303
New +$8.02M 0.12% 82

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Wealth Enhancement Advisory Services's CRL Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Charles River Laboratories (CRL) stake by 0.98% in Q2 2026, buying an estimated $6.77K and bringing the position to 3,896 shares worth $909K. The position accounts for ﹤0.01% of the portfolio, ranked #2142.

Wealth Enhancement Advisory Services first reported a position in CRL in Q3 2021 and has held it in 13 quarters since. The position peaked at $8.3M in Q3 2021. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Wealth Enhancement Advisory Services held 3,896 shares of Charles River Laboratories worth $909K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 38 Charles River Laboratories shares in Q2 2026, an estimated $6.77K.
  • Charles River Laboratories made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2142 holding.
  • Wealth Enhancement Advisory Services first reported a position in Charles River Laboratories in Q3 2021 and has held it in 13 quarters since.
  • Wealth Enhancement Advisory Services's Charles River Laboratories position peaked at $8.3M in Q3 2021.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.